Smart­Dye­Liv­ery devel­ops patented processes to trans­port ther­a­peu­tics into the tar­get tis­sue in a highly spe­cific and effec­tive man­ner. Com­pared to con­ven­tional meth­ods, the deliv­ery of

Nova­Pump is a spe­cial­ized med­ical tech­nol­ogy com­pany based in Jena, Ger­many, which devel­ops prod­ucts for inter­ven­tional car­diac sup­port together with an exter­nal net­work and then

Nine out of ten strokes are pre­ventable. Pre­ven­ti­cus devel­ops tech­nolo­gies and med­ical care pro­grams that make this goal achiev­able every day. A major risk for

HAPILA offers cus­tomers from the phar­ma­ceu­ti­cal and biotech indus­tries com­plete solu­tions for chem­i­cal and process engi­neer­ing prob­lems. In addi­tion to the devel­op­ment of chem­i­cal syntheses,

InflaRx is a Nasdq-listed inno­v­a­tive biotech­nol­ogy com­pany. InflaRx devel­ops first-in-class drugs against acute and chronic inflam­ma­tory dis­eases. The main focus is on the devel­op­ment of

eZono devel­ops, pro­duces and dis­trib­utes state-of-the-art tablet ultra­sound devices. The lat­est model ‘eZono 5000’ has a unique nee­dle guid­ance sys­tem, eZGuide, which enables two-dimen­­sional freehand